Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Methyldopa

From Wikipedia, the free encyclopedia
Medication used to treat high blood pressure
Pharmaceutical compound
Methyldopa
Skeletal formula of methyldopa
Ball-and-stick model of the methyldopa molecule
Clinical data
Trade namesAldomet, Aldoril, Dopamet, others
Other namesα-Methyl-L-DOPA; α-Methyl-levodopa; α-Methyl-DOPA;L-α-Methyl-3,4-dihydroxyphenylalanine
AHFS/Drugs.comMonograph
MedlinePlusa682242
License data
Pregnancy
category
Routes of
administration
By mouth,intravenous
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability~50%
MetabolismLiver
Onset of action4–6 hours[1]
Eliminationhalf-life105 minutes
Duration of action10–48 hours[1]
ExcretionKidney for metabolites
Identifiers
  • (S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.008.264Edit this at Wikidata
Chemical and physical data
FormulaC10H13NO4
Molar mass211.217 g·mol−1
3D model (JSmol)
  • C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O
  • InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1 ☒N
  • Key:CJCSPKMFHVPWAR-JTQLQIEISA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Methyldopa, also known asα-methyl-L-DOPA and sold under the brand nameAldomet among others, is amedication used forhigh blood pressure.[1] It is one of the preferred treatments forhigh blood pressure in pregnancy.[1] For other types of high blood pressure includingvery high blood pressure resulting in symptoms other medications are typically preferred.[1] It can be givenby mouth orinjection into a vein.[1] Onset of effects is around 5 hours and they last about a day.[1]

Common side effects include sleepiness.[1] More severe side effects includered blood cell breakdown, liver problems, andallergic reactions.[1] Methyldopa is in thealpha-2 adrenergic receptor agonist family of medication. It works by stimulating the brain to decrease the activity of thesympathetic nervous system.[1]

Methyldopa was discovered in 1960.[2] It is on theWorld Health Organization's List of Essential Medicines.[3]

Medical uses

[edit]

Methyldopa is used in theclinical treatment of the followingdisorders:

Side effects

[edit]

Methyldopa is capable of inducing a number of adverse side effects, which range from mild to severe. Nevertheless, they are generally mild when the dose is less than 1 gram per day.[5] Side effects may include:

Withdrawal

[edit]

Reboundhypertension viawithdrawal on account oftolerance upon the abrupt discontinuation of methyldopa has been reported.[6]

Mechanism of action

[edit]

The mechanism of action of methyldopa is not fully clear. It may reduce thedopaminergic andserotonergic transmission in the central andperipheral nervous system and it indirectly affectsnorepinephrine (noradrenaline) synthesis by way of inhibiting dopamine synthesis. Methyldopa acts onalpha-2 adrenergic receptors, which are found on the pre synaptic nerve terminal.[1] This inhibits the release of norepinephrine from the presynaptic neuron.

The S-enantiomer of methyldopa is a competitive inhibitor of theenzymearomaticL-amino acid decarboxylase (LAAD), which convertsL-DOPA intodopamine.L-DOPA can cross theblood–brain barrier and thus methyldopa may have similar effects. LAAD converts it intoalpha-methyldopamine, a false precursor to norepinephrine, which in turn reduces synthesis of norepinephrine in the vesicles.Dopamine beta hydroxylase (DBH) converts alpha-methyldopamine intoalpha-methylnorepinephrine, which is anagonist of the presynapticα2-adrenergic receptor causing inhibition of neurotransmitter release.

Methyldopa has been found to be amonoamine depleting agent.[7]

Pharmacokinetics

[edit]

Maximum decrease in blood pressure occurs 4–6 hours after oral dosage. The half-life of methyldopa is 105 minutes.[8] Methyldopa exhibits variableabsorption from thegastrointestinal tract. It ismetabolized in theliver andintestines and isexcreted inurine.[citation needed]

History

[edit]

When methyldopa was first introduced, it was the mainstay of antihypertensivetreatment, but its use has declined on account of relatively severe adverse side effects, with increased use of other safer and more tolerable agents such asalpha blockers,beta blockers, andcalcium channel blockers. Additionally, it has yet to be associated with reducing adverse cardiovascular events including myocardial infarction and stroke, or overall all-cause mortality reduction in clinical trials.[9] Nonetheless, one of methyldopa's still current indications is in the management ofpregnancy-induced hypertension (PIH), as it is relatively safe inpregnancy compared to many other antihypertensives which may affect thefetus.[citation needed]

See also

[edit]

References

[edit]
  1. ^abcdefghijk"Methyldopa". The American Society of Health-System Pharmacists.Archived from the original on 21 December 2016. Retrieved8 December 2016.
  2. ^Walker RS (2012).Trends and Changes in Drug Research and Development. Springer Science & Business Media. p. 109.ISBN 978-94-009-2659-2.Archived from the original on 2016-09-14.
  3. ^World Health Organization (2019).World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization.hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  4. ^Malha L, Podymow T, August P (2018)."39 - Hypertension in Pregnancy".Hypertension: A Companion to Braunwald's Heart Disease (3rd ed.).Elsevier. pp. 361–373.doi:10.1016/B978-0-323-42973-3.00039-1.ISBN 978-0-323-42973-3.
  5. ^Bnf (September 2008).British National Formulary 56. pp. 95–96.ISBN 978-0-85369-778-7.
  6. ^Methyldopa (PIM 342)Archived 2008-03-13 at theWayback Machine
  7. ^Tung CS, Goldberg MR, Hollister AS, Sweetman BJ, Robertson D (1988). "Depletion of brainstem epinephrine stores by alpha-methyldopa: possible relation to attenuated sympathetic outflow".Life Sci.42 (23):2365–2371.doi:10.1016/0024-3205(88)90190-7.PMID 3287081.
  8. ^"DailyMed - METHYLDOPA tablet, film coated".dailymed.nlm.nih.gov. Retrieved2022-07-25.
  9. ^Mah GT, Tejani AM, Musini VM (October 2009)."Methyldopa for primary hypertension".The Cochrane Database of Systematic Reviews.2009 (4) CD003893.doi:10.1002/14651858.CD003893.pub3.PMC 7154320.PMID 19821316.

External links

[edit]
Wikimedia Commons has media related toMethyldopa.
Sympatholytic (and closely related)antihypertensives (C02)
Sympatholytics
(antagonizeα-adrenergic
vasoconstriction)
Central
α2-Adrenergic receptor agonists
Adrenergic release inhibitors
Imidazoline receptor agonists
Ganglion-blocking/nicotinic antagonists
Peripheral
Indirect
Monoamine oxidase inhibitors
VMAT inhibitors
Tyrosine hydroxylase inhibitors
Direct
α1-Adrenergic receptor blockers
Non-selective α-adrenergic receptor blockers
Otherantagonists
Serotonin receptor antagonists
Endothelin receptor antagonists (forPHTooltip Pulmonary hypertension)
Dopaminergics
DAprecursors
DA receptoragonists
MAO-Binhibitors
COMTinhibitors
AAADinhibitors
Anticholinergics
Others
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
Non-specific
AAADTooltip Aromatic L-amino acid decarboxylase
MAOTooltip Monoamine oxidase
Phenethylamines
(dopamine,epinephrine,
norepinephrine)
PAHTooltip Phenylalanine hydroxylase
THTooltip Tyrosine hydroxylase
DBHTooltip Dopamine beta-hydroxylase
PNMTTooltip Phenylethanolamine N-methyltransferase
COMTTooltip Catechol-O-methyl transferase
Tryptamines
(serotonin,melatonin)
TPHTooltip Tryptophan hydroxylase
AANATTooltip Serotonin N-acetyl transferase
ASMTTooltip Acetylserotonin O-methyltransferase
Histamine
HDCTooltip Histidine decarboxylase
HNMTTooltip Histamine N-methyltransferase
DAOTooltip Diamine oxidase
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Methyldopa&oldid=1312768390"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp